ResMed
730 hedge funds and large institutions have $19.7B invested in ResMed in 2022 Q4 according to their latest regulatory filings, with 115 funds opening new positions, 235 increasing their positions, 244 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 244
6% less capital invested
Capital invested by funds: $21.1B → $19.7B (-$1.32B)
27% less funds holding in top 10
Funds holding in top 10: 15 → 11 (-4)
Holders
730
Holding in Top 10
11
Calls
$50.6M
Puts
$30.6M
Top Buyers
| 1 | +$53.6M | |
| 2 | +$50.2M | |
| 3 | +$46.4M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$45.6M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$40.1M |
Top Sellers
| 1 | -$436M | |
| 2 | -$105M | |
| 3 | -$80.7M | |
| 4 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
-$53.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$40.3M |